(Q35882832)

10 August 2017

1 reference

title

Preclinical studies of opioids and opioid antagonists on gastrointestinal function (English)

1 reference

Beverley Greenwood-Van Meerveld

10 August 2017

0 references

1

object named as

Greenwood-Van Meerveld B

1 reference

10 August 2017

Gardner CJ

2

1 reference

10 August 2017

Little PJ

3

1 reference

10 August 2017

Hicks GA

4

1 reference

10 August 2017

Dehaven-Hudkins DL

5

1 reference

10 August 2017

publication date

1 October 2004

1 reference

Neurogastroenterology and Motility

10 August 2017

published in

1 reference

10 August 2017

volume

16 Suppl 2

1 reference

10 August 2017

page(s)

46-53

1 reference

Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Distribution and chemical coding of orphanin FQ/nociceptin-immunoreactive neurons in the myenteric plexus of guinea pig intestines and sphincter of Oddi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Sites of action of morphine on the ascending excitatory reflex in the guinea-pig small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Enkephalins modulate inhibitory neuromuscular transmission in circular muscle of human colon via delta-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Electrophysiological evidence for different release mechanism of ATP and NO as inhibitory NANC transmitters in guinea-pig colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Antisense oligodeoxynucleotides to mu- and delta-opioid receptor mRNA block the enhanced effects of opioids during intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

The expression of delta- and kappa-opioid receptor is enhanced during intestinal inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Contrasting Actions of Intrathecal U50, 488H, Morphine, or [D-Pen sup 2, D-Pen sup 5] Enkephalin or Intravenous U50, 488H on the Visceromotor Response to Colorectal Distension in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

J.J. Bonica Lecture--2000: Physiology, pathophysiology, and pharmacology of visceral pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Arylacetamide kappa-opioid receptor agonists produce a tonic- and use-dependent block of tetrodotoxin-sensitive and -resistant sodium currents in colon sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

The use of quaternary narcotic antagonists in opiate research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

A review of the potential role of methylnaltrexone in opioid bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Quaternary naltrexone reverses morphine-induced behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Selective postoperative inhibition of gastrointestinal opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

Alvimopan∗∗Alvimopan is the official USAN name adopted as of press time. (ADL 8-2698) Is a Novel Peripheral Opioid Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-3150.2004.00555.X

10.1111/J.1743-3150.2004.00555.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference